valproate | CARLAT PUBLISHING

Research Update

Lithium, Valproate Have Low (and Similar) Risk of Kidney Injury

November 1, 2024

Alex Evans, PharmD, MBA.

Alex Evans, PharmD, MBA. Dr. Evans has no financial relationships with companies related to this material.

Research explores the kidney injury risks associated with lithium compared to valproate, revealing unexpected findings.

Bipolar Upgrade 4: from Valproate to Functioning

August 28, 2023

Kellie Newsome, PMHNP and Chris Aiken, MD

Updates from the 2023 International Bipolar Conference: Avoid valproate (Depakote) in women of childbearing age; who to blame when patients are noncompliant; and functioning trumps symptom reduction.

Psychopharm Commandment 4: Lamotrigine Rash

October 24, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

How to assess, treat, and when you can restart after a lamotrigine rash.

Unpacking Aggression Associated with ADHD

October 18, 2021

John C. Blader, PhD

John C. Blader, PhD

Child and adolescent psychologist at the University of Texas Health Science Center, San Antonio, TX. Dr. Blader has disclosed that he has received funding from Supernus Pharmaceuticals for one research grant unrelated to this topic and these medications. Dr. Feder has reviewed this article and found no evidence of bias in this educational activity.

We often see children and teens who have ADHD with aggressive behavior. The press to treat them often results in polypharmacy with all the attendant risks and complications. This interview with Dr. Joseph Blader discusses research findings that can help us to provide more effective simplified and safer treatment for many of the patients.